US EditionPublished • loading... • Updated
Missed Out on Eli Lilly? This GLP-1 Stock Could Be a Bargain Buy.
Summary by The Motley Fool
1 Articles
1 Articles
Missed Out on Eli Lilly? This GLP-1 Stock Could Be a Bargain Buy.
Key PointsEli Lilly's stock trades at more than 30 times forward earnings, which is a steep price to pay right now.Amgen is a much cheaper option by comparison.It also has a promising GLP-1 treatment in MariTide, which may only need to be taken quarterly.10 stocks we like better than Amgen › Eli Lilly (NYSE: LLY) is the most valuable healthcare company in the world, with a market cap of around $950 billion. In the past five years, the stock pric…
·Alexandria, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
